<qa>  What is the primary aim of this trial?The primary aim of this trial is to determine whether lymphadenectomy, used to restrict adjuvant therapy other than vaginal brachytherapy to node positive women, results in a non-inferior survival as compared to adjuvant therapy given to all women with high risk apparent stage 1 endometrial cancer. 